[First XXXX in @entity162 : clinical differentiation and functional impact in an Argentinean national sample].

@entity1 @entity73 @entity162 @entity716
BACKGROUND: @entity162 in its early phase results in a diagnostic and therapeutic challenge for the clinician. Individuals with @entity162 can be grouped according with their different clinical features such as the presence or absence of @entity716 . Early illness detection and treatment is usually associated with a better prognosis. OBJECTIVE: The main objective of this study was to compare the clinical features, functionality and stigma of @entity1 with @entity162 with @entity716 at onset. METHOD: A total sample of 175 @entity162 outpatients completed clinical assessment (YMRS and HAM-D), functionality (FAST), and stigma (ISE) scales. All @entity1 were clinically stable for at least three months and were following active maintenance treatment regimens. RESULTS: The @entity716 group consisted of 70 @entity1 and the non- @entity716 group 105 @entity1 . Statistical significant differences were found between @entity1 with and without @entity716 features regarding sex, age at diagnosis, perceived @entity73 . Bipolar @entity1 with @entity716 at onset received an early treatment. DISCUSSION: Clinical differences found in both groups of @entity162 @entity1 have therapeutic implications which may account for different outcomes. Differential interventions could be designed according to each clinical group. Special attention should be paid to @entity162 first episode features.
